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a  b  s  t  r  a  c  t
Objectives:  Complications  of  pharyngitis  (peritonsillar  abscess,  retropharyngeal  abscess,  and  cervical  cel-
lulitis) are  rare, but  appear  to be on the increase  over  recent  years  and many  of  these  patients  have
been  treated  by  anti-inﬂammatory  drugs  prior  to admission.  The purpose  of this  study  was to review  the
current  epidemiological  data  concerning  these  complications  and  investigate  a  possible  correlation  with
anti-inﬂammatory  drug use.
Material  and methods:  A single-centre  retrospective  review  of epidemiological,  clinical  and  microbi-
ological  data  was  performed  on the  medical  charts  of  patients  hospitalised  for  peritonsillar  abscess,
retropharyngeal  abscess  or cervical  cellulitis  between  2005  and  2010.
Results:  Over  a six-year  period,  163  patients  were  hospitalised  for complications  of pharyngitis,  with a
sex-ratio  of  1.82  (104/57).  The  number  of  cases  of  peritonsillar  abscess  (PTA)  increased  from  13  to  28
cases  per year  from  2005  to 2010  and  the  number  of  cases  of  retropharyngeal  abscess  increased  from
three  to  six cases  per  year  over  the  same  period.  The  number  of  cases  of  cellulitis  remained  stable  with
an  average  of  1.82  cases  per  year.  Each  year,  signiﬁcantly  more  patients  with  an  abscess  were  admitted
to  our  unit  with a history  of anti-inﬂammatory  drug  use  (13.3  ±  4.6)  than  without  anti-inﬂammatory
drug use (7.8  ±  4.3)  (P < 0.01).  Micro-organisms  were  identiﬁed  in 80%  of cases,  with  mixed  strains  in  73%
of  cases,  Streptococcus  in  72% of  samples  and  Streptococcus  pyogenes  in  19% of  cases  of PTA. A  favourable
outcome  was  observed  in  all patients  in  response  to  medical  and  surgical  treatment.
Conclusion:  In line  with  the  literature,  we observed  an  increasing  incidence  of  complications  of  pharyn-
gitis.  The  present  series  comprised  signiﬁcantly  more  patients  admitted  for  PTA with  a  history  of
anti-inﬂammatory  drug  use.  A  multicentre  prospective  controlled  study  in  Nantes  on  a large  cohort
is  currently  underway  and  will  probably  conﬁrm  these  preliminary  results.
© 2014  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
Pharyngitis and sore throat are common and usually benign
iseases [1]. However, they can be responsible for infectious
omplications with an incidence ranging between 16 to 37 per
00,000 inhabitants [2–5]. These complications are rare, but poten-
ially serious, such as peritonsillar abscess (PTA), retropharyngeal
bscess, and can even be life-threatening, in the case of cervical
ellulitis.
The incidence of local complications of pharyngitis and sore
hroat is currently on the increase [6], especially in children
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879-7296/© 2014 Elsevier Masson SAS. All rights reserved.[7,8]. These data from the literature are concordant with data
from French national health databases. Several explanations can
be proposed, such as a lower rate of prescription of antibiotics
and increased consumption of anti-inﬂammatory drugs. How-
ever, management of pharyngitis must comply with the treatment
guidelines clearly deﬁned by the Agence Franc¸ aise de Sécurité San-
itaire des Produits de Santé (French Agency of health security of
products of health) (AFSSAPS) [9]. Anti-inﬂammatory drugs are not
recommended in the pharyngitis treatment ﬂow-chart, but pre-
scription of an antibiotic is often associated with treatment by
anti-inﬂammatory drugs. Self-prescribed medication is also a com-
mon  practice, as patients have easy access to anti-inﬂammatory
molecules.
Anti-inﬂammatory drugs have been incriminated by many
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hickenpox [10–12], and PTA in the course of infectious mononu-
leosis [13], although a statistical correlation has not been clearly
stablished.
The objectives of this study, based on a series of 163 patients,
ere to describe the recent epidemiological data concerning perit-
nsillar abscess, retropharyngeal abscess and cervical cellulitis and
o investigate a possible correlation between these complications
nd previous use of anti-inﬂammatory drugs.
. Material and methods
A single-centre retrospective review was performed on the
edical charts of 163 patients hospitalised in our otorhinolaryn-
ology and head and neck surgery department for management
f peritonsillar abscess (PTA), retropharyngeal abscess or sup-
urative cervical cellulitis between January 2005 and December
010. Cases were identiﬁed from the French PMSI database. Three
ypes of data were recorded for each patient: epidemiological (age,
ender, admission and discharge dates), microbiological (culture
nd bacterial identiﬁcation, resistance) and clinical (patient’s pre-
ospital and in-hospital management, antibiotic therapy, surgical
reatment, tracheotomy, surgical revision, outcome, ﬁrst episode,
elevant history, immunodepression, diabetes, subsequent tonsil-
ectomy).
Patients with purulent pharyngitis or any other upper respi-
atory tract infection not considered to be a complication of
haryngitis (such as epiglottitis or abscess of the base of the tongue)
ere excluded.
Statistical analysis was performed with Excel and XLSTAT soft-
are (Student’s test). Quantitative data were expressed as the




From January 2005 to December 2010, 127 adult patients (105
ales and 58 females, i.e. a sex-ratio of 1.82) were hospitalisedor management of PTA, 23 for retropharyngeal abscess and 13 for
ervical cellulitis (Fig. 1).
Thirteen patients were hospitalised for PTA in 2005 versus 31

















Fig. 1. Number of cases of PTA, retropharyngeal abscess and ceogy, Head and Neck diseases 131 (2014) 299–303
PTA increased from three cases in 2005 to seven cases in 2009
and six cases in 2010. The number of cases of cervical cellulitis
remained stable, with an average of 1.82 cases/year over these
last six years. In 2010, PTA represented 80% of all complications
of pharyngitis, while retropharyngeal abscess accounted for 17%
and cervical cellulitis accounted for 3%. Over this six-year period,
we observed signiﬁcantly more cases of peritonsillar abscess than
retropharyngeal abscess and cellulitis (P < 0.05).
Males accounted for 65% of cases of PTA, 61% of cases of
retropharyngeal abscess and 69% of cases of cervical cellulitis. The
median age was 32 years (range: 16–76) for PTA, versus 50 years
for cervical cellulitis (range: 21–86) and retropharyngeal abscess
(range: 19–79).
The mean length of hospital stay was four days (range: 1–9) for
PTA, eight days (range: 4–26) for retropharyngeal abscess and 17
days (range: 8–38) for cervical cellulitis. Median length of hospital
stay was  four days for PTA and 7 days for retropharyngeal abscess
and 17 days for cervical cellulitis.
3.2. Bacteriological data
A pus sample for a bacteriological examination was  sys-
tematically realized when a pus sample was obtained during
aspiration-incision or surgical drainage, and was contributive in
131 patients (80%). In contrast, ﬁve samples (3%) remained sterile,
especially in cases of cervical cellulitis. No bacteria were identi-
ﬁed on 27 (17%) of the 163 aspiration samples performed (blank
aspirates or bacteriological examination not performed), includ-
ing 26 samples from patients with PTA (20%) (Table 1). One or
several micro-organisms were identiﬁed in 97 (76%) of the 127
cases of PTA. Bacteriological examination was contributive for
22 (96%) of the 23 samples of retropharyngeal abscess and 12
(92%) of the 13 samples of cervical cellulitis gave positive bacte-
riology results. Multiple bacterial strains were identiﬁed, with at
least two  bacteria identiﬁed in 67 (70%) PTA samples, 15 (66%)
retropharyngeal abscess samples and 10 (77%) cervical cellulitis
samples. Aerobic bacteria were isolated in 83% of PTA samples,
with group A, B, F, G or nongroupable Streptococcus (n = 90), Entero-
coccus (n = 7) and Staphylococcus aureus (n = 4). Anaerobic bacteria
were isolated in 17% of PTA samples [Fusobacterium sp.  (n = 8),
Peptostreptococcus sp.  (n = 4) and Prevotella sp.  (n = 8)], 22% of






rvical cellulitis hospitalised per year from 2005 to 2010.
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Table  1
Bacterial identiﬁcation in PTA.
Aerobes n
Gram + cocci























































tute the ﬁrst-line of defence against pathogenic agents [16–18].Prevotella sp 8
.3. Clinical data
.3.1. History
Seventy-three (58%) of the 127 patients in this series presented
ith a ﬁrst episode of PTA, while 54 patients had a history of a
revious episode of PTA (42%). Six per cent of patients were diabetic.
o patient presented severe immunodepression. One case of PTA
as observed in a patient treated with methotrexate and one case
f retropharyngeal abscess was observed in a patient treated with
zathioprine.
.3.2. Pre-hospital management
Of the 163 patients developing complications of pharyngitis, 101
62%) had already been treated by antibiotics prior to their admis-
ion to hospital: 87 (68%) of the patients with PTA had already
eceived antibiotics, in combination with anti-inﬂammatory drug
herapy in 66 patients (52%) or alone in 21 patients (17%). For
7 (43%) of the patients who had received antibiotic therapy
rior to admission to hospital, this treatment did not comply
ith the guidelines established by the AFSSAPS [9]. Twenty-one
atients were treated with amoxicillin + clavulanic acid at a dose
reater than or equal to two grams daily, 10 patients were treated
ith ﬁrst-line macrolides, four patients were treated with syner-
istins, one patient received penicillin M and one patient received
 combination of amoxicillin + clavulanic acid and metronidazole.
re-hospital antibiotic therapy complied with guidelines in 48
55%) patients: amoxicillin alone at a dose greater than or equal
o two grams daily for 23 patients, third-generation cephalosporin
or 24 patients, and ﬁrst-generation cephalosporin for 1 patient.
he type of antibiotic prescribed was not reported for two patients
2%).
Of the 127 patients with PTA, 80 (63%) had taken corticoste-
oids or non-steroidal anti-inﬂammatory drugs: 14 had taken an
nti-inﬂammatory drug without antibiotics (11%) and 66 (52%)
ad taken an anti-inﬂammatory drug in combination with an
ntibiotic. A non-steroidal anti-inﬂammatory drug was used by
6 patients (45%), and corticosteroids were used by 35 patients
44%). Nine patients (11%) had received a combination of cortico-
teroids and non-steroidal anti-inﬂammatory drugs. Each year, a
igniﬁcantly higher proportion of patients with abscess was admit-
ed to our ward after having been treated with anti-inﬂammatoryogy, Head and Neck diseases 131 (2014) 299–303 301
drugs (13.3 ± 4.6) compared to patients not previously treated with
anti-inﬂammatory drugs (7.8 ± 4.3) (P < 0.01).
Eleven patients (47%) with retropharyngeal abscess had
received anti-inﬂammatory drug treatment, without antibiotics in
three patients (11%). No signiﬁcant difference in the rates of pre-
hospital anti-inﬂammatory drug treatment was  observed among
the patients with retropharyngeal abscess. Anti-inﬂammatory drug
treatment was reported in eight patients (62%) with cervical
cellulitis. A total of 98 patients (60%) had therefore received anti-
inﬂammatory drugs before admission to hospital, regardless of the
type of complication.
A statistically signiﬁcant difference was  demonstrated between
the number of patients with PTA treated by anti-inﬂammatory
drugs, either alone or in combination with an antibiotic (13.3 ± 4.6)
and the number of patients treated by antibiotics alone (3.5 ± 3.4)
(P < 0.01). A statistically signiﬁcant difference was also observed
between the number of patients with peritonsillar abscess receiv-
ing pre-hospital treatment with anti-inﬂammatory drugs and
antibiotics (11 ± 4.9) and those treated with anti-inﬂammatory
drugs alone (2.3 ± 1.2) (P < 0.01).
3.3.3. Hospital management
All patients with PTA were treated by incision-aspiration, under
local anaesthesia in 109 cases (86%) and under general anaesthesia
in 18 cases (14%). Twelve patients were reoperated under gen-
eral anaesthesia (9%) following an unfavourable course: ten via an
intra-oral approach and two via a combined intra-oral approach
and neck incision. All patients had a satisfactory outcome following
medical and surgical treatment. Twenty-two patients (17%) were
subsequently treated by tonsillectomy.
All retropharyngeal abscesses were drained under general
anaesthesia via an intra-oral approach, combined with neck inci-
sion in two cases (6%). One patient was treated by concomitant
tonsillectomy. Six patients (26%) required reoperation via neck inci-
sion following cervical extension of the infection. Six patients (26%)
were tracheotomised, four during initial management and two dur-
ing reoperation.
Patients with cervical cellulitis were drained by neck inci-
sion under general anaesthesia (GA) and by combined intra-oral
approach and neck incision in one patient. Eight patients (62%)
underwent immediate tracheotomy, six patients (46%) required
reoperation and two patients (15%) were treated by hyperbaric
oxygen therapy (Table 2).
4. Discussion
The growing incidence of complications of pharyngitis has been
reported by several epidemiological studies [6,7]. The causal role
of anti-inﬂammatory drugs in the development of these com-
plications remains controversial. No risk factor has been clearly
identiﬁed at the present time, but anti-inﬂammatory drugs have
been regularly implicated [6,13–15]. Many studies, mostly ret-
rospective, recommend cautious use of anti-inﬂammatory drugs
especially in patients with chickenpox [10–12] or infectious
mononucleosis [13]. In a prospective study published in 2011,
G. Voiriot et al. demonstrated that exposure to NSAIDs (non-
steroidal anti-inﬂammatory drugs) at the beginning of acute
community-acquired pneumonia was  associated with the develop-
ment of pleuropulmonary complications, especially empyema [16].
It has also been clearly demonstrated that, in vitro, NSAIDs inhibit
the function of neutrophil polymorphonuclear cells, which consti-This retrospective study based on 163 patients allowed an
updated review of the epidemiological characteristics of PTA,
retropharyngeal abscess and cervical cellulitis. The present data
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Table 2
Summary of data.
Patients Total PTA Retropharyngeal abscess Cervical cellulitis
n 163 127 23 13
Epidemiological data
Age (years) 44 [32–50] 32 [16–76] 50 [19–79] 50 [21–86]
Male/Female 105/58 82/45 14/9 9/4
Length of hospital stay (days) 6 [1–38] 4 [1–9] 7 [4–26] 17 [8–38]
Pre-hospital treatment n (%)
None 43 (26%) 26 (20%) 13 (56%) 4 (31%)
Antibiotic (ATB) 22 (14%) 21 (17%) 0 (0%) 1 (8%)
ATB  + anti-inﬂammatory drugs 79 (48%) 66 (52%) 7 (31%) 6 (46%)
Anti-inﬂammatory drugs only 19 (12%) 14 (11%) 3 (44%) 2 (15%)
Hospital treatment n (%)
LA/GA 109/54 109/18 0/23 0/13
Tracheotomy 11 (7%) 0 (0%) 3 (13%) 8 (62%)
Reoperation 24 (14%) 12 (9%) 6 (26%) 6 (46%)
Intake  of AI drugs n (%)
NSAIDs 41 (42%) 36 (45%) 3 (27%) 2 (25%)
Steroids 48 (48%) 35 (44%) 7 (64%) 6 (75%)
NSAIDs + steroids 10 (10%) 9 (11%) 1 (9%) 0 (0%)
Bacteriological data n (%)










































oAnaerobes 33 (20%) 22
SAIDs: non-steroidal anti-inﬂammatory drugs; ATB: antibiotic; GA: general anaes
onﬁrm that PTA is a disease of young adults, as the median age
n this series was 32 years [2–6], while patients with retropharyn-
eal abscess and cervical cellulitis are older with a mean of age of 50
ears. Neither immunodepression nor diabetes were identiﬁed as
isk factors in this study [1], but, in view of the small sample sizes
n this series, a larger population would be necessary to demon-
trate a possible association. The most common previous illnesses
n these patients were PTA and repeated episodes of pharyngitis
6]. A male predominance was observed with a sex-ratio of 1.82, in
ontrast with the results of previous studies [4–6].
Bacterial identiﬁcation was possible in 76% of cases of PTA and
5% of cases of cervical cellulitis, with multistrain ﬂora in 73% of
amples. These infections were mainly due to oropharyngeal and
asopharyngeal ﬂora. The most commonly isolated bacteria were
treptococcus for aerobic organisms and Fusobacterium for anaer-
bic organisms. These data are consistent with the data of the
iterature [2,3,6]. In the light of these results and in order to reduce
ealth expenditure, systematic bacteriological examination may
ave only a limited value and a microbiological diagnostic work-
p might only be really indicated in debilitated patients [19,20],
s, in most cases, bacterial identiﬁcation does not modify empirical
ntibiotic therapy.
This study conﬁrmed the increasing incidence of these compli-
ations, as the number of cases of PTA and retropharyngeal abscess
ore than doubled between 2005 and 2010. Inappropriate pre-
ospital management of sore throat and pharyngitis appeared to
e one of the explanations for this recent increase, as few patients
re admitted with no previous treatment. Sixty three per cent of
atients with PTA in this study had received anti-inﬂammatory
reatment and the group of patients with PTA comprised a sig-
iﬁcantly greater proportion of patients previously treated with
nti-inﬂammatory drugs (P < 0.05). However, no signiﬁcant differ-
nce in pre-hospital anti-inﬂammatory drug treatment rates was
bserved in the retropharyngeal abscess group, probably because
f the smaller number of cases. More than six out of 10 patients
ith PTA in our series had already received antibiotic therapy,
ither complying or not complying with AFSSAPS guidelines, with
igniﬁcantly more patients treated with anti-inﬂammatory and
ntibiotic combination therapy, conﬁrming the results reported
y Pinaud et al., who suggested that the combination of anti-
nﬂammatory drugs and antibiotics did not prevent development
f PTA [6].) 5 (22%) 6 (46%)
; LA: local anaesthesia.
In 2010, in a series of 17 patients with cervical cellulitis, Thiebaut
reported nine patients who had already received corticosteroids
or non-steroidal anti-inﬂammatory drugs, but no statistically sig-
niﬁcant difference was demonstrated [14]. In a more recent study
based on 130 patients with cervical cellulitis, Petitpas et al. [15]
reported that corticosteroids, but not NSAIDs, were a signiﬁcant
risk factor for extension of cervical cellulitis to mediastinitis, but
failed to elucidate the real pathophysiological mechanisms.
In conclusion, no studies are available in the literature demon-
strating, with a high level of proof, a statistical association between
the development of complications of pharyngitis and previous use
of anti-inﬂammatory drugs. Conversely, some authors, such as
Ozbeck et al. [21], recommended a single dose of corticosteroids
to ensure better relief of pain, trismus and fever, without increas-
ing the risks of an unfavourable outcome. Similarly, Page et al.
[22] proposed a treatment regimen comprising a local procedure
(aspiration or drainage) associated with antibiotic therapy and cor-
ticosteroid therapy, while emphasizing that corticosteroid therapy,
like non-steroidal anti-inﬂammatory drugs, must never be used
alone without antibiotic cover, because of a probably considerable
risk of deterioration and/or dissemination of the infection [22]. The
mean length of hospital stay in this study was  two days versus four
days in our series, suggesting that anti-inﬂammatory drugs, pre-
scribed in the right indications and following medical and surgical
treatment, could be beneﬁcial.
In this series, 63% of patients with PTA and 62% of patients with
cervical cellulitis had received anti-inﬂammatory drugs prior to
admission to hospital and a statistically signiﬁcant difference was
demonstrated between the number of patients with PTA treated by
anti-inﬂammatory drugs alone or in combination with antibiotics
and the number of patients treated by antibiotics alone (P < 0.01).
A statistically signiﬁcant difference was also observed between
the number of patients with PTA in whom pre-hospital man-
agement consisted of a combination of anti-inﬂammatory drugs
and antibiotics (11 ± 4.9) versus anti-inﬂammatory drugs alone
(2.3 ± 1.2) (P < 0.01). This high proportion of patients treated by
anti-inﬂammatory drugs is possibly related to self-prescribed med-
ication but also medical prescriptions. Anti-inﬂammatory drugs
are less and less frequently prescribed alone and are therefore
often associated with antibiotics. However, as suggested by Pin-
aud et al. and as conﬁrmed by our study, this combination does










































abscesses. Otolaryngol Head Neck Surg 1999;120(1):57–61.
[21] Ozbek C, et al. Use of steroids in the treatment of peritonsillar abscess. J LaryngolJ. Demeslay et al. / European Annals of Otorhinolar
nti-inﬂammatory drugs increase the risk of complications has not
et been elucidated. However, by delaying speciﬁc management,
hey lead to late diagnosis, sometimes at the stage of complications
16–18].
It is generally accepted that hospital management of compli-
ations of pharyngitis must be both medical and surgical [6,7,22].
reatment of PTA may  consist of ﬁrst-line drainage under local
naesthesia. In the present series, only 12 patients with PTA
equired reoperation under GA due to an unfavourable course.
ll cases of retropharyngeal abscess and cervical cellulitis were
rained under GA. Immediate tracheotomy was performed in 62%
f patients with cervical cellulitis versus only 13% of patients with
etropharyngeal abscess.
These results clearly illustrate the high morbidity of cervi-
al cellulitis, as reﬂected by the reoperation rate, as 6 out of 13
atients had to be reoperated because of an unfavourable course,
ometimes progressing to mediastinitis [14]. Management of these
omplications must therefore comprise two main components:
arly surgical management under local or general anaesthesia
epending on the extent of the infection, possibly associated with
racheotomy and empirical antibiotic therapy effective on strepto-
occi and anaerobic bacteria.
. Conclusion
There is a marked increase in the number of complications
elated to pharyngitis at the present time, as conﬁrmed by the
esults of this study, which also showed that anti-inﬂammatory
rugs were signiﬁcantly associated with these complications. A
ulticentre prospective controlled study, may  be able to provide a
eﬁnitive answer to this question.
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